Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach
Grigorieva, J.; Asmellash, S.; Net, L.; Tsypin, M.; Roder, H.; Roder, J. Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach. Int. J. Mol. Sci. 2020, 21, 838. https://doi.org/10.3390/ijms21030838
Grigorieva J, Asmellash S, Net L, Tsypin M, Roder H, Roder J. Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach. International Journal of Molecular Sciences. 2020; 21(3):838. https://doi.org/10.3390/ijms21030838
Chicago/Turabian StyleGrigorieva, Julia, Senait Asmellash, Lelia Net, Maxim Tsypin, Heinrich Roder, and Joanna Roder. 2020. "Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach" International Journal of Molecular Sciences 21, no. 3: 838. https://doi.org/10.3390/ijms21030838